Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
Cefamandole 3 g daily gave poor results in the treatment of severe purulent respiratory infections in 50 patients. A further 71 patients were treated with 4 g daily and the results were excellent with 86% clinical success. Apart from muscle pain with the injection, side-effects were minimal.
D000368:Aged; D002435:Cefamandole / Q000009:adverse effects / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002511:Cephalosporins; D002435:Cefamandole